INSYS Therapeutics was a commercial-stage specialty pharmaceutical company that developed and commercialized innovative supportive care products.

They had two marketed products; SUBSYS, a proprietary sublingual fentanyl spray for breakthrough cancer pain and their Dronabinol SG Capsule, an improved second-line treatment for chemotherapy-induced nausea, CINV, and anorexia associated with weight loss in patients with AIDS. Their lead pipeline product candidate was Dronabinol Oral Solution, a proprietary orally-administered liquid formulation of Dronabinol.

These products require high Clean Room standards for processing and packaging which Studio8 was able to accomplish with Federal Standard 209E Class 10,000 (ISO7) Clean Room.